Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Aethlon Medical Fiscal Second Quarter 2025 Earnings and Corporate Update. [Operator Instructions] Please note this event is being recorded.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.09 | 334 | Director | 16,641 | 2020-12-17 | Filing | |
$2.10 | 5,417 | Director | 16,975 | 2020-12-17 | Filing | |
$2.11 | 21,101 | Director | 22,392 | 2020-12-17 | Filing | |
$0.34 | 4,900 | Director | 282,174 | 2010-04-13 | Filing | |
$0.34 | 12,500 | Director | 287,074 | 2010-04-12 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 21,224 | $46,481 | 0% | |
2. | 20,274 | $44,400 | 0% | |
3. | 7,340 | $16,075 | 0% | |
4. | 1,318 | $2,886 | 0% | |
5. | 1,080 | $2,365 | 0% |